Đang chuẩn bị liên kết để tải về tài liệu:
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ

The value of chemotherapy in soft tissue sarcoma (STS) remains controversial. Several expert teams consider that chemotherapy provides a survival advantage and should be proposed in high-risk (HR) patients. However, the lack of accuracy in identifying HR patients with conventional risk factors (large, deep, FNCLCC grade 3, extremity STS) is an issue that cannot be neglected. |

TÀI LIỆU LIÊN QUAN

Ebook Value-based Marketing: Marketing Strategies for Corporate Growth and Shareholder Value - Peter Doyle

Product redesigning, cost reduction, component substitution, and their influence in value management in micro and small enterprises

Employer attractiveness: Measurement scale development and validation

Valuation Measuring and Managing the Value of Companies

Bài giảng Chapter 2: Time Value of Money

Lecture Chapter 5: Introduction to Valuation: The Time Value of Money

Vietnam tea industry: An analysis from value chain approach

Lecture Managerial finance - Chapter 2: Time value of money

Solving a nonlinear biharmonic boundary value problem

Evaluating total operational value and associated risks of financial holding companies in Taiwan